Related Experiment Video
Updated: Mar 30, 2026

Induction of Atherosclerotic Plaques Through Activation of Mineralocorticoid Receptors in Apolipoprotein E-deficient Mice
Published on: September 26, 2018
Association of Chlamydia pneumoniae Infection With Atherosclerotic Plaque Formation
Omid Assar1, Azim Nejatizadeh, Farzaneh Dehghan
1Alborz University of Medical Sciences, Karaj, Iran. gama.epage@gmail.com.
Insights
Chlamydia pneumoniae DNA was detected in nearly 30% of atherosclerotic plaques from patients with coronary artery disease. This finding supports a significant association between Chlamydia pneumoniae infection and atherosclerosis development.
Area of Science:
- Infectious Diseases
- Cardiovascular Medicine
- Microbiology
Background:
- Atherosclerosis is a complex disease with multifactorial origins.
- The role of infectious agents, particularly Chlamydia pneumoniae, in atherosclerosis pathogenesis remains debated.
- Conflicting evidence necessitates further investigation into microbial involvement.
Purpose of the Study:
- To investigate the presence and significance of Chlamydia pneumoniae DNA in atherosclerotic plaques.
- To determine the association between Chlamydia pneumoniae and coronary artery disease.
- To compare bacterial presence in diseased arteries versus control tissues.
Main Methods:
- A cross-sectional study involving 85 patients undergoing coronary artery bypass grafting (CABG).
- Control group comprised thoracic biopsies from 85 individuals.
- Nested polymerase chain reaction (PCR) was employed to detect Chlamydia pneumoniae DNA in collected specimens.
Main Results:
- Chlamydia pneumoniae DNA was identified in 29.4% (25/85) of atherosclerotic plaques.
- The bacterium was detected in 5.9% (5/85) of internal thoracic artery samples from the control group.
- A statistically significant association (P=0.0001) was found between C. pneumoniae positivity in atherosclerotic plaques and the control group.
Conclusions:
- The study findings support the hypothesis linking Chlamydia pneumoniae to atherosclerosis.
- Chlamydia pneumoniae may be an associated factor in the development of coronary artery disease.
- Further research is warranted to elucidate the precise role of this bacterium in cardiovascular pathology.
Abstract:
Atherosclerosis is a complex multifactorial disorder. Studies show that infectious microbial agents may play an important role in the development of atherosclerosis; however, these findings are conflicting. This study investigated the presence of Chlamydia pneumoniae DNA in atherosclerotic plaques of patients suffering from coronary artery disease. In a cross-sectional study, 85 patients (43 females and 42 males with mean age of 61±9.5, range 42-82 years) referred for coronary artery bypass grafting (CABG) and thoracic biopsy as the control groups were enrolled for this study. Standard questionnaires, including demographic and clinical evaluation were administered. Obtained specimens were processed and then nested polymerase chain reaction with primers for Pst1 fragment was carried out to detect Chlamydia pneumoniae DNA. Statistical analysis was done using the SPSS software. Of note, in 25 out of the 85 patients (29.4%), C. pneumoniae was detected within atherosclerotic plaques, whereas, 5 out of the 85 thoracic biopsy (5.9%) were positive for the presence of the mentioned bacteria in internal thoracic artery. There was a statistically significant association between atherosclerotic plaque (study group) and thoracic biopsy (control group) in terms of C. pneumoniae positivity (P= 0.0001). The findings of this study support the hypothesis that C. pneumoniae is associated with atherosclerosis.
Related Concept Videos
Atherosclerosis I: Introduction
Coronary Artery Disease II: Pathophysiology
Coronary Artery Disease I: Introduction
Inflammation
Peripheral Artery Disease I: Introduction
Bacterial Phylum Chlamydiae

